News
04-29-2010, 04:20 AM
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced financial results for the quarter ended March 31, 2010, provided an update on progress towards achievement of 2010 goals as well as 2010 financial guidance.
More... (http://www.news-medical.net/news/20100429/AVEO-Pharmaceuticals-reports-net-loss-of-24144-million-for-first-quarter-2010.aspx)
More... (http://www.news-medical.net/news/20100429/AVEO-Pharmaceuticals-reports-net-loss-of-24144-million-for-first-quarter-2010.aspx)